Active	Status	Sponsor type	Region	Phase	Filter
1 Active 7 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
zotiraciclib (TG02) / Cothera Biosci
NCT05588141: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations	Recruiting	1/2	96	US	Zotiraciclib	National Cancer Institute (NCI)	Brain Tumor, Cancer	08/25	08/29
SB2602 / S*BIO
No trials found
SB2312 / S*BIO
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
zotiraciclib (TG02) / Cothera Biosci
NCT05588141: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations	Recruiting	1/2	96	US	Zotiraciclib	National Cancer Institute (NCI)	Brain Tumor, Cancer	08/25	08/29
SB2602 / S*BIO
No trials found
SB2312 / S*BIO
No trials found